Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $472.37 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $208.84 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $159.00 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32.29 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $29.90 | 2 | $0 (2021) |
| Amgen Inc. | $14.93 | 1 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $14.15 | 1 | $0 (2021) |
| Boston Scientific Corporation | $13.26 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.98 | 6 | Janssen Pharmaceuticals, Inc ($62.59) |
| 2023 | $82.67 | 5 | E.R. Squibb & Sons, L.L.C. ($46.27) |
| 2022 | $134.29 | 7 | E.R. Squibb & Sons, L.L.C. ($74.28) |
| 2021 | $133.43 | 9 | E.R. Squibb & Sons, L.L.C. ($42.16) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 07/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.84 | General |
| Category: Cardiovascular | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.29 | General |
| Category: Cardiovascular | ||||||
| 09/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Cardiovascular | ||||||
| 06/27/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Cardiovascular | ||||||
| 05/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Cardiovascular | ||||||
| 09/08/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: Cardiovascular | ||||||
| 08/03/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Cardiovascular | ||||||
| 05/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.68 | General |
| Category: Cardiovascular | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Cardiovascular | ||||||
| 09/21/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardio-renal | ||||||
| 08/24/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.76 | General |
| Category: Cardiovascular | ||||||
| 08/18/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiology | ||||||
| 08/16/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: Cardiovascular | ||||||
| 08/13/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardio-renal | ||||||
| 08/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 65 | $10,159 | $4,096 |
| 2021 | 3 | 63 | 63 | $11,434 | $6,014 |
| 2020 | 3 | 45 | 50 | $9,110 | $4,008 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 34 | $4,182 | $1,756 | 42.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 16 | $2,512 | $1,243 | 49.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $3,465 | $1,097 | 31.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $3,880 | $2,313 | 59.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 28 | $4,284 | $2,246 | 52.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,270 | $1,456 | 44.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 17 | $4,571 | $2,097 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 16 | $2,448 | $1,090 | 44.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 17 | $2,091 | $822.13 | 39.3% |
About Janet Daltner, CRNP
Janet Daltner, CRNP is a Nurse Practitioner healthcare provider based in Wexford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1780025528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janet Daltner, CRNP has received a total of $472.37 in payments from pharmaceutical and medical device companies, with $121.98 received in 2024. These payments were reported across 27 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($472.37).
As a Medicare-enrolled provider, Daltner has provided services to 165 Medicare beneficiaries, totaling 178 services with total Medicare billing of $14,119. Data is available for 3 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Wexford, PA
- Active Since 07/09/2013
- Last Updated 07/09/2013
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1780025528
Products in Payments
- XARELTO (Drug) $159.00
- ELIQUIS (Drug) $156.71
- CAMZYOS (Drug) $52.13
- FARXIGA (Drug) $32.29
- Kerendia (Drug) $29.90
- Repatha (Biological) $14.93
- Livalo (Drug) $14.15
- BodyGuardian (Device) $13.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Wexford
Mrs. Deborah Anderson, Crnp, CRNP
Nurse Practitioner — Payments: $4,478
Lea Ochs, Crnp, CRNP
Nurse Practitioner — Payments: $3,034
Miss. Angela Ravotti, Crnp, CRNP
Nurse Practitioner — Payments: $2,355
Jessica Spagnolo, Crnp, CRNP
Nurse Practitioner — Payments: $1,971
Mrs. M Sullivan, Crnp, CRNP
Nurse Practitioner — Payments: $1,373
Mrs. Barbara Kepes, Crnp, CRNP
Nurse Practitioner — Payments: $1,034